52 related articles for article (PubMed ID: 17133467)
1. Growth factors during HCV therapy may be "cost-effective", but are they "effective"?
Muir AJ; McHutchison JG
Hepatology; 2006 Dec; 44(6):1400-3. PubMed ID: 17133467
[No Abstract] [Full Text] [Related]
2. Evaluating the evidence from clinical trials in chronic hepatitis C.
Brown RS
J Viral Hepat; 2006 May; 13 Suppl 1():15-25. PubMed ID: 16630043
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of hepatitis C: therapeutic management].
Bourliere M
Gastroenterol Clin Biol; 2008 May; 32(5 Pt 2):S166-71. PubMed ID: 18482813
[No Abstract] [Full Text] [Related]
4. Combination therapy with ribavirin and amantadine in renal transplant patients with chronic hepatitis C virus infection is not superior to ribavirin alone.
Calanca LN; Fehr T; Jochum W; Fischer-Vetter J; Müllhaupt B; Wüthrich RP; Ambühl PM
J Clin Virol; 2007 May; 39(1):54-8. PubMed ID: 17409018
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of chronic viral hepatitis].
Pedersen C; Pedersen CR
Ugeskr Laeger; 2008 Jun; 170(24):2137-40. PubMed ID: 18565297
[TBL] [Abstract][Full Text] [Related]
6. The cost of treating ribavirin-induced anemia in hepatitis C: the impact of using recombinant human erythropoietin.
Devine EB; Cross JT; Kowdley KV; Sullivan SD
Curr Med Res Opin; 2007 Jun; 23(6):1463-72. PubMed ID: 17559739
[TBL] [Abstract][Full Text] [Related]
7. Ribavirin in chronic hepatitis C: past and future.
Loustaud-Ratti V; Rousseau A; Marquet P; Denis F; Alain S
Expert Rev Anti Infect Ther; 2009 Apr; 7(3):249-53. PubMed ID: 19344238
[No Abstract] [Full Text] [Related]
8. Productivity improvements in hepatitis C treatment: impact on efficacy, cost, cost-effectiveness and quality of life.
Lidgren M; Hollander A; Weiland O; Jönsson B
Scand J Gastroenterol; 2007 Jul; 42(7):867-77. PubMed ID: 17558912
[TBL] [Abstract][Full Text] [Related]
9. [Ribavirin].
Taéron C
Rev Infirm; 2009; (152):47-9. PubMed ID: 19702029
[No Abstract] [Full Text] [Related]
10. Management and therapy of chronic hepatitis C virus infection in HIV-infected individuals.
Mauss S
J HIV Ther; 2007 Mar; 12(1):11-7. PubMed ID: 17589391
[TBL] [Abstract][Full Text] [Related]
11. Study Results Support Telaprevir-Based Therapy for HCV.
AIDS Patient Care STDS; 2010 Nov; 24(11):746. PubMed ID: 21108519
[No Abstract] [Full Text] [Related]
12. Improving anti-HCV therapy.
Pol S; Mallet VO
Discov Med; 2006 Oct; 6(35):187-90. PubMed ID: 17234140
[TBL] [Abstract][Full Text] [Related]
13. Review article: the treatment of hepatitis C virus recurrence after liver transplantation.
Arjal RR; Burton JR; Villamil F; Rosen HR
Aliment Pharmacol Ther; 2007 Jul; 26(2):127-40. PubMed ID: 17593060
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin for ribavirin-induced anemia in hepatitis C: more answers but many more questions.
Dev A; Patel K; Muir A; McHutchison JG
Am J Gastroenterol; 2003 Nov; 98(11):2344-7. PubMed ID: 14638332
[No Abstract] [Full Text] [Related]
15. [Economic evaluation of combined therapy in chronic hepatitis C].
Casado MA; Buti M; Fosbrook L; Esteban R
Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():57-62. PubMed ID: 11968346
[No Abstract] [Full Text] [Related]
16. Ribavirin trials and hantavirus--what we should not conclude.
Marcus KA; Johann-Liang R; Powers JH
Clin Infect Dis; 2005 May; 40(10):1550-1. PubMed ID: 15844085
[No Abstract] [Full Text] [Related]
17. Benefit vs. harm of treatment of chronic hepatitis C.
Steinberg J
Am Fam Physician; 2005 Apr; 71(8):1489; author reply 1489-90. PubMed ID: 15864891
[No Abstract] [Full Text] [Related]
18. Tinkering and tailoring with HCV therapy: can we get away with less?
Zekry A; Patel K; Muir A; McHutchison JG
Hepatology; 2004 Dec; 40(6):1249-51. PubMed ID: 15558725
[No Abstract] [Full Text] [Related]
19. 'HepConomics': cost-effective, indeed, but how can we pay for it?
Athanasakis K; Petrakis I; Kyriopoulos J
J Viral Hepat; 2015 Aug; 22(8):682. PubMed ID: 25727161
[No Abstract] [Full Text] [Related]
20. Does patient cost sharing for HCV drugs make sense?
Lakdawalla DN; Linthicum MT; Vanderpuye-Orgle J
Am J Manag Care; 2016 May; 22(6 Spec No.):SP188-90. PubMed ID: 27266947
[No Abstract] [Full Text] [Related]
[Next] [New Search]
